We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+14.43%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$160M
AUM Growth
+$54M
(+51%)
Cap. Flow
+$57M
Cap. Flow
% of AUM
35.58%
Top 10 Holdings %
Top 10 Hldgs %
68.37%
Holding
60
New
15
Increased
12
Reduced
1
Closed
20
Top Buys
| 1 |
Gyre Therapeutics
GYRE
|
+$23.6M |
| 2 |
Sanofi
SNY
|
+$17M |
| 3 |
Biogen
BIIB
|
+$9.9M |
| 4 |
Merck
MRK
|
+$6.5M |
| 5 |
Kura Oncology
KURA
|
+$5.17M |
Top Sells
| 1 |
GSK
GSK
|
+$11.6M |
| 2 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
+$7.06M |
| 3 |
AET
Aetna Inc
AET
|
+$4.75M |
| 4 |
Emergent Biosolutions
EBS
|
+$4.25M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$3.43M |
Sector Composition
| 1 | Healthcare | 89.09% |
| 2 | Financials | 3.34% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gyre Therapeutics
GYRE
$719M
| $29.7M | 18.53% |
153,332
+126,361
| +469% | +$23.6M |
|
|
2
Sanofi
SNY
$103B
| $16.4M | 10.23% |
+408,621
| New | +$17M |
|
|
3
Kura Oncology
KURA
$985M
| $12.3M | 7.7% |
657,411
+265,384
| +68% | +$5.17M |
|
4
Elevance Health
ELV
$83.1B
| $11.5M | 7.19% |
52,387
+7,941
| +18% | +$1.87M |
|
|
5
Biogen
BIIB
$27.9B
| $8.73M | 5.45% |
+31,900
| New | +$9.9M |
|
6
UnitedHealth
UNH
$380B
| $6.51M | 4.06% |
30,400
+18,970
| +166% | +$4.33M |
|
7
Eli Lilly
LLY
$1.02T
| $6.37M | 3.98% |
82,363
+28,463
| +53% | +$2.29M |
|
|
8
Merck
MRK
$306B
| $6.26M | 3.91% |
+120,369
| New | +$6.5M |
|
9
Boston Scientific
BSX
$63.3B
| $6.16M | 3.85% |
225,463
+75,711
| +51% | +$2.06M |
|
10
Viking Therapeutics
VKTX
$4.35B
| $5.58M | 3.48% |
1,276,845
+26,595
| +2% | +$147K |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.55M | 3.46% |
28,653
+5,453
| +24% | +$1.09M |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $5.35M | 3.34% |
31,635
-26,454
| -46% | -$4.75M |
|
13
HCA Healthcare
HCA
$82B
| $5.08M | 3.17% |
+52,330
| New | +$5.08M |
|
14
Icon
ICLR
$13.1B
| $4.28M | 2.67% |
36,200
+12,596
| +53% | +$1.44M |
|
|
ACH
15
Accendra Health
ACH
$280M
| $4.25M | 2.66% |
+273,640
| New | +$4.88M |
|
|
TBRG
16
DELISTED
TruBridge
TBRG
| $3.33M | 2.08% |
113,860
+89,317
| +364% | +$2.67M |
|
|
CFMS
17
DELISTED
Conformis, Inc. Common Stock
CFMS
| $3.19M | 1.99% |
+88,027
| New | +$3.69M |
|
18
Omnicell
OMCL
$2.11B
| $3.05M | 1.9% |
+70,226
| New | +$3.23M |
|
19
Philips
PHG
$25.9B
| $2.94M | 1.84% |
101,101
+11,742
| +13% | +$349K |
|
20
Viatris
VTRS
$19B
| $2.84M | 1.77% |
+69,000
| New | +$2.94M |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $2.78M | 1.74% |
+31,180
| New | +$2.99M |
|
|
LITS
22
Lite Strategy Inc
LITS
$33.9M
| $1.94M | 1.21% |
46,728
+5,382
| +13% | +$234K |
|
|
HRC
23
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.87M | 1.17% |
+21,449
| New | +$1.83M |
|
|
DERM
24
DELISTED
Dermira, Inc.
DERM
| $1.52M | 0.95% |
+190,300
| New | +$4.14M |
|
|
EPZM
25
DELISTED
Epizyme, Inc
EPZM
| $1.29M | 0.81% |
+72,826
| New | +$1.23M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA